Immuno-microbiota cross and talk: The new paradigm of metabolic diseases

Seminars in Immunology

Volumn 24, Issue 1, 2012, Pages 67-74

  Burcelin, Rémy ^a,b   Garidou, Lucile ^a,b   Pomié, Céline ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Diabetes; Innate immunity; Intestinal microbiota; Metabolic diseases; Obesity

Indexed keywords

BACTERIAL ANTIGEN; INSULIN;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; CHRONIC INFLAMMATION; ENVIRONMENTAL FACTOR; EPIDEMIC; HEREDITY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; METABOLIC DISORDER; MICROFLORA; NONHUMAN; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; DIET, HIGH-FAT; HUMANS; IMMUNITY, INNATE; INTESTINES; METABOLIC SYNDROME X; METAGENOME;

EID: 84857058546     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.11.011     Document Type: Review

References (100)

1. Jacquemont S., Reymond A., Zufferey F., Harewood L., Walters R.G., Kutalik Z., et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 2011, 478:97-102.
2. Beck-Nielsen H., Vaag A., Poulsen P., Gaster M. Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects-experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 2003, 17:445-467.
3. Poulsen P., Andersen G., Fenger M., Hansen T., Echwald S.M., Volund A., et al. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?. Diabetes 2003, 52:194-198.
4. Medici F., Hawa M., Ianari A., Pyke D.A., Leslie R.D. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999, 42:146-150.
5. Burcelin R., Crivelli V., Dacosta A., Roy-Tirelli A., Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 2002, 282:E834-E842.
6. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
7. Roux S., Faubladier M., Mahul A., Paulhe N., Bernard A., Debroas D., et al. Metavir: a web server dedicated to virome analysis. Bioinformatics 2011, 27:3074-3075.
8. Phan T.G., Kapusinszky B., Wang C., Rose R.K., Lipton H.L., Delwart E.L. The fecal viral flora of wild rodents. PLoS Pathog 2011, 7:e1002218.
9. Minot S., Sinha R., Chen J., Li H., Keilbaugh S.A., Wu G.D., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 2011, 21:1616-1625.
10. Dethlefsen L., Eckburg P.B., Bik E.M., Relman D.A. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006, 21:517-523.
11. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
12. Fanaro S., Chierici R., Guerrini P., Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003, (91):48-55.
13. Xu J., Gordon J.I. Inaugural Article: honor the symbionts. Proc Natl Acad Sci USA 2003, 100:10452-10459.
14. Mackie R.I., Sghir A., Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999, 69:1035S-1045S.
15. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005, 102:11070-11075.
16. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
17. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
18. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
19. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
20. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
21. Hu B., Elinav E., Flavell R.A. Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle 2011, 10:1936-1939.
22. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
23. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
24. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
25. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004, 101:15718-15723.
26. Turnbaugh P., Ridaura V., Faith J., Rey F., Knight R., Gordon J. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009, 1:6-14.
27. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007, 104:979-984.
28. Pickup J.C., Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
29. Caspar-Bauguil S., Cousin B., Galinier A., Segafredo C., Nibbelink M., Andre M., et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005, 579:3487-3492.
30. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009, 15:930-939.
31. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
32. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.
33. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
34. Shoelson S., Lee J., Goldfine A. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801.
35. Amar J., Burcelin R., Ruidavets J., Cani P., Fauvel J., Alessi M., et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008, 87:1219-1223.
36. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
37. Cani P.D., Possemiers S., et al. " Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability" Gut 2009, 58(8):1091-1103.
38. Poggi M., Bastelica D., Gual P., Iglesias M.A., Gremeaux T., Knauf C., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007, 50:1267-1276.
39. Membrez M., Blancher F., et al. " Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice" FASEB J 2008, 22(7):2416-2426.
40. Pappo I., Becovier H., Berry E.M., Freund H.R. Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 1991, 51:106-112.
41. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011, 3:559-572.
42. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
43. Erridge C., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007, 86:1286-1292.
44. Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50:90-97.
45. Neal M.D., Leaphart C., Levy R., Prince J., Billiar T.R., Watkins S., et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 2006, 176:3070-3079.
46. Rensen P.C., Oosten M., Bilt E., Eck M., Kuiper J., Berkel T.J. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 1997, 99:2438-2445.
47. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., et al. Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
48. Yu B., Hailman E., Wright S.D. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997, 99:315-324.
49. Kumwenda Z.L., Wong C.B., Johnson J.A., Gosnell J.E., Welch W.J., Harris H.W. Chylomicron-bound endotoxin selectively inhibits NF-kappaB activation in rat hepatocytes. Shock 2002, 18:182-188.
50. Westerterp M., Berbee J.F., Pires N.M., van Mierlo G.J., Kleemann R., Romijn J.A., et al. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 2007, 116:2173-2181.
51. Song M.J., Kim K.H., Yoon J.M., Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006, 346:739-745.
52. Bouloumie A., Casteilla L., Lafontan M. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?. Arterioscler Thromb Vasc Biol 2008, 28:1211-1213.
53. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006, 116:115-124.
54. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184.
55. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23.
56. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116:1494-1505.
57. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
58. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003, 112:91-100.
59. Shi C., Jia T., Mendez-Ferrer S., Hohl T.M., Serbina N.V., Lipuma L., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34:590-601.
60. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
61. Capel F., Klimcakova E., Viguerie N., Roussel B., Vitkova M., Kovacikova M., et al. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization. Diabetes 2009, 58:1558-1567.
62. Patsouris D., Li P.P., Thapar D., Chapman J., Olefsky J.M., Neels J.G. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008, 8:301-309.
63. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med 2009, 15:940-945.
64. Prunet-Marcassus B., Cousin B., Caton D., Andre M., Penicaud L., Casteilla L. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 2006, 312:727-736.
65. Galinier A., Carriere A., Fernandez Y., Carpene C., Andre M., Caspar-Bauguil S., et al. Adipose tissue proadipogenic redox changes in obesity. J Biol Chem 2006, 281:12682-12687.
66. Ehses J.A., Meier D.T., Wueest S., Rytka J., Boller S., Wielinga P.Y., et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 2010, 53:1795-1806.
67. Schertzer J.D., Tamrakar A.K., Magalhaes J.G., Pereira S., Bilan P.J., Fullerton M.D., et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 2011, 60:2206-2215.
68. Vijay-Kumar M., Carvalho F.A., Aitken J.D., Fifadara N.H., Gewirtz A.T. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur J Immunol 2010, 40:3528-3534.
69. Carvalho F.A., Aitken J.D., Gewirtz A.T., Vijay-Kumar M. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol 2011, 4:102-111.
70. Youm Y.H., Adijiang A., Vandanmagsar B., Burk D., Ravussin A., Dixit V.D. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 2011, 152:4039-4045.
71. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011, 17:179-188.
72. Mathis D., Shoelson S.E. Immunometabolism: an emerging frontier. Nat Rev Immunol 2011, 11:81.
73. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008, 103:467-476.
74. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
75. Yang H., Youm Y.H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010, 185:1836-1845.
76. Littman D.R., Rudensky A.Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010, 140:845-858.
77. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
78. Ilan Y., Maron R., Tukpah A.M., Maioli T.U., Murugaiyan G., Yang K., et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci USA 2010, 107:9765-9770.
79. Mantell B.S., Stefanovic-Racic M., Yang X., Dedousis N., Sipula I.J., O'Doherty R.M. Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity. PLoS One 2011, 6:e19831.
80. Ohmura K., Ishimori N., Ohmura Y., Tokuhara S., Nozawa A., Horii S., et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010, 30:193-199.
81. Zuniga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 2010, 185:6947-6959.
82. Duffaut C., Galitzky J., Lafontan M., Bouloumie A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009, 384:482-485.
83. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011, 17:610-617.
84. Brugman S., Klatter F.A., Visser J.T., Wildeboer-Veloo A.C., Harmsen H.J., Rozing J., et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 2006, 49:2105-2108.
85. Wen L., Ley R., et al. " Innate immunity and intestinal microbiota in the development of Type 1 diabetes" Nature 2008, 455(7216):1109-1113.
86. Alam C., Valkonen S., Palagani V., Jalava J., Eerola E., Hanninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010, 59:2237-2246.
87. Westerholm-Ormio M., Vaarala O., Pihkala P., Ilonen J., Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003, 52:2287-2295.
88. Badami E., Sorini C., Coccia M., Usuelli V., Molteni L., Bolla A.M., et al. Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes. Diabetes 2011, 60:2120-2124.
89. Aranda R., Sydora B.C., McAllister P.L., Binder S.W., Yang H.Y., Targan S.R., et al. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol 1997, 158:3464-3473.
90. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010, 10:735-744.
91. Hapfelmeier S., Muller A.J., Stecher B., Kaiser P., Barthel M., Endt K., et al. Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med 2008, 205:437-450.
92. Manicassamy S., Reizis B., Ravindran R., Nakaya H., Salazar-Gonzalez R.M., Wang Y.C., et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
93. Siddiqui K.R., Laffont S., Powrie F. E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity 2010, 32:557-567.
94. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001, 167:5067-5076.
95. Evrard B., Coudeyras S., Dosgilbert A., Charbonnel N., Alame J., Tridon A., et al. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 2011, 6:e18735.
96. Foligne B., Zoumpopoulou G., Dewulf J., Ben Younes A., Chareyre F., Sirard J.C., et al. A key role of dendritic cells in probiotic functionality. PLoS One 2007, 2:e313.
97. Walton K.L., He J., Kelsall B.L., Sartor R.B., Fisher N.C. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function. Immunol Lett 2006, 102:16-24.
98. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258.
99. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., Magness S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010, 5:e12191.
100. Amar J., Serino M., et al. " Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept" Diabetologia 2011, 54(12):3055-3061.